| __timestamp | Corcept Therapeutics Incorporated | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 26551000 | 64538000 |
| Thursday, January 1, 2015 | 50286000 | 71914000 |
| Friday, January 1, 2016 | 81321000 | 108973000 |
| Sunday, January 1, 2017 | 159201000 | 141102000 |
| Monday, January 1, 2018 | 251247000 | 251453000 |
| Tuesday, January 1, 2019 | 306486000 | 120282000 |
| Wednesday, January 1, 2020 | 353874000 | 186419000 |
| Friday, January 1, 2021 | 365978000 | 277133000 |
| Saturday, January 1, 2022 | 401858000 | 196245000 |
| Sunday, January 1, 2023 | 482375000 | 131314000 |
Cracking the code
In the competitive world of biotechnology, Corcept Therapeutics Incorporated and Ligand Pharmaceuticals Incorporated have shown distinct revenue trajectories over the past decade. From 2014 to 2023, Corcept Therapeutics has experienced a remarkable growth, with its revenue increasing by over 1,700%, from approximately $26.6 million to $482.4 million. This growth highlights Corcept's strategic advancements and successful product offerings.
Conversely, Ligand Pharmaceuticals has seen a more modest revenue journey. Starting at around $64.5 million in 2014, Ligand's revenue peaked in 2018 at $251.5 million, before declining to $131.3 million in 2023. This fluctuation may reflect market challenges or strategic shifts within the company.
These contrasting revenue paths underscore the dynamic nature of the biotech industry, where innovation and market adaptation are key to sustained success.
argenx SE vs Corcept Therapeutics Incorporated: Examining Key Revenue Metrics
Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated: Examining Key Revenue Metrics
Breaking Down Revenue Trends: Dr. Reddy's Laboratories Limited vs Corcept Therapeutics Incorporated
Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Jazz Pharmaceuticals plc and Corcept Therapeutics Incorporated: A Comprehensive Revenue Analysis
Revenue Insights: Halozyme Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Performance Compared
Revenue Insights: Grifols, S.A. and Corcept Therapeutics Incorporated Performance Compared
Revenue Insights: Corcept Therapeutics Incorporated and Veracyte, Inc. Performance Compared
Corcept Therapeutics Incorporated vs Merus N.V.: Examining Key Revenue Metrics
Who Generates More Revenue? Cytokinetics, Incorporated or Ligand Pharmaceuticals Incorporated
Revenue Insights: Alkermes plc and Ligand Pharmaceuticals Incorporated Performance Compared
Annual Revenue Comparison: Ligand Pharmaceuticals Incorporated vs Evotec SE